Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BGT226 |
| Trade Name | |
| Synonyms | NVP-BGT226 |
| Drug Descriptions |
BGT226 is a dual inhibitor of class I PI3K kinases and mTOR, which may inhibit tumor celll proliferation and tumor growth (PMID: 21976531, PMID: 31190275). |
| DrugClasses | mTOR Inhibitor 51 PI3K Inhibitor (Pan) 42 |
| CAS Registry Number | 1245537-68-1 |
| NCIT ID | C74073 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BGT226 | BGT226 | 1 | 0 |
| BGT226 + Imatinib | BGT226 Imatinib | 0 | 0 |
| BGT226 + Nilotinib | BGT226 Nilotinib | 0 | 0 |
| BGT226 + Olverembatinib | BGT226 Olverembatinib | 0 | 0 |